Medicine and Dentistry
Atrial Fibrillation
100%
Patient
75%
Inpatient
57%
Apoplexy
45%
Antithrombotic
36%
Therapeutic Procedure
32%
Cohort Analysis
28%
Heart Failure
22%
Thromboembolism
20%
Death
18%
Thrombosis
17%
Vitamin K Antagonist
16%
Cardiology
15%
Diet and Cancer
14%
Anticoagulation
13%
Brain Ischemia
12%
Follow up
11%
Health
11%
Heart Disease
11%
Mortality
11%
CHA2DS2-VASc Score
11%
Position
11%
Acute Coronary Syndrome
11%
Female
10%
Major Bleeding
10%
Prognosis
10%
Age
9%
Death
9%
Analysis
7%
Embolism
7%
Diabetes Mellitus
7%
Diagnosis
7%
Association
6%
Risk Stratification
6%
Bleeding
6%
Hazard Ratio
6%
Diabetes
5%
Cause of Death
5%
Antithrombotic Therapy
5%
Cardiovascular System
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
33%
Atrial Fibrillation
29%
Anticoagulant Agent
17%
Dabigatran
11%
Warfarin
10%
Rivaroxaban
6%
Apixaban
6%
Bleeding
6%
Vascular Disease
6%
Antivitamin K
6%